Schaeffer's Top Stock Picks for '25

Stocks Climb As Dow Eyes 5th Straight Win

The Dow touched a record high earlier today

Managing Editor
Oct 3, 2018 at 12:07 PM
facebook X logo linkedin


U.S. stocks are confidently higher today, with the Dow Jones Industrial Average (DJI) up triple digits and fresh off a record high. The blue-chip index is heading toward its fifth straight win, which would mark its longest winning streak since July, thanks to an encouraging jobs report this morning. The S&P 500 Index (SPX) and Nasdaq Composite (IXIC) are in the black as well, boosted by surging bank and tech stocks. Elsewhere, the Cboe Volatility Index (VIX), or Wall Street's "fear gauge," is on track for its lowest close since Aug. 9. 

Continue reading for more on today's market, including:

  • The Dow stock hit with a rare downgrade.
  • The chicken stock Guggenheim is buying.
  • Plus, options bears pile on a sinking aluminum stock; General Motors rallies on Honda team-up; and Nektar Therapeutics' rough week continues.

Midday Market Stats Oct 3

 
Century Aluminum Co (NASDAQ:CENX) is sporting unusual options volume today, with roughly 13,000 calls and 4,500 puts on the tape -- 15 times the intraday norm. The November 11 and 13 calls are leading the charge, while the October 9 and 10 puts are popular today, as well, with opening activity detected at each strike. CENX stock has plummeted 11.9% at $10.49, fresh off an annual low of $9.85, even as aluminum prices rise.
 
General Motors Company (NYSE:GM) is sitting near the top of the S&P 500 today, with the shares 1.9% higher at $33.83, on reports of Honda Motor will take a 5.7% stake in GM's self-driving vehicle division. Lately, General Motors stock has been digging a channel of lower lows and highs, culminating in an annual low of $33.20 yesterday. Despite the positive price action today, the shares have still shed 15.6% in 2018, with breakout attempts in recent months contained by their 40-day moving average.
 
MMC Daily Chart General Motors

 

On the other hand, Nektar Therapeutics (NASDAQ:NKTR) stock is near the bottom of the S&P 500, extending its recent skid after Monday's bear note. At last check, NKTR was down was down 2.5% to trade at $53.93. The drug stock has shed 11.5% this week, but has still more than doubled off its lows of $22.72 from nearly a year ago. 

 
 

Which of These SUB-$5 Stocks Could 26x From Here? (AD)

He called a rare 11x on Tesla…

Then he called a 26x on Workhorse…

Then an even rarer 35x on Nio Inc…

Now Tim Bohen says these 5 tiny “America First” stocks are next up in 2025.

They’re trading for less than $5 right now.

But thanks to Elon & Trump’s new alliance…

They could be off to the races in Trump’s first 100 days.

And right now for a limited time…

You can get the names & tickers for just $1 here. (AD)

10 Stock Picks FREE
 
 

Featured Articles from Trusted Partners:

🚀 One Stock Pick Could Change Everything in 2025
What if one stock pick could define your success next year? Get 10 expert-vetted stocks set for 2025—plus 5 bonus picks to watch now. Get the Report →

🆕 New Options Need New Trading Strategies
Zero-DTE options are the newest (and hottest) options to trade.  Professional traders have rushed into the market and are making a mint.  Don’t get left behind - learn all about these options, how to trade them, market setups to profit from, plus much more. Download now →

👀 Revealed: 3 Defensive Stocks for Your Portfolio
Worried about the market? This free report reveals 3 under-the-radar defensive stocks for uncertain times in any kind of economy.

 

 
 

FREE Report Download

 

Follow us on X, Follow us on Twitter